CLOVER HEALTH INVESTMENTS CO

$CLOV

← All companies Sign in to track

Institutional coverage

10 13F filers hold $CLOV.

13F holders

10

Insider buys · 90d

0

Congress · 90d

0

Smart Money · top-200 alpha cohort

No exposure this quarter

No top-200 alpha managers currently hold $CLOV. The institutional holders table below shows the broader 13F picture.

Institutional holders

Top 10 of 10 · Source: 13F-HR

Vanguard Group Inc.

Renaissance Technologies

0.02% of portfolio

0.01% of portfolio

Gmt Capital Corp.

0.36% of portfolio

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Tudor Investment Corp. Et Al

0.01% of portfolio

WINTON GROUP Ltd

0.03% of portfolio

Aigen Investment Management, LP

0.02% of portfolio

Insider activity · last 90 days

50 transactions · 10 filers

17 Aug 2026

▼ SOLD

—

—

S

13 Aug 2026

· GRANT

—

—

A

13 Aug 2026

· GRANT

—

—

A

10 Aug 2026

▼ SOLD

—

—

S

20 Jul 2026

▼ SOLD

—

—

S

17 Jul 2026

▼ SOLD

—

—

S

16 Jul 2026

▼ SOLD

—

—

S

16 Jul 2026

▼ SOLD

—

—

S

16 Jul 2026

▼ SOLD

—

—

S

16 Jul 2026

▼ SOLD

—

—

S

16 Jul 2026

▼ SOLD

—

—

S

09 Jul 2026

▼ SOLD

—

—

S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $CLOV in the recent window.

Convergence · $CLOV

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 17:07 UTC.